Does Adiponectin Upregulation Attenuate the Severity of Acute Pancreatitis in Obesity?

Hayder H. Al-Azzawi, Kathryn M. Ziegler, Deborah A. Swartz-Basile, Sue Wang, Henry A. Pitt, Nicholas Zyromski

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: Obesity is an independent risk factor for severe acute pancreatitis, though the mechanisms underlying this association are unknown. The powerful anti-inflammatory adipokine adiponectin is decreased in obesity. We recently showed that the severity of pancreatitis in obese mice is inversely related to circulating adiponectin levels, and therefore hypothesized that adiponectin upregulation would attenuate the severity of pancreatitis in obese mice. Methods: Forty congenitally obese mice were studied. Seven days prior to study, 20 mice received a single tail vein injection of adenovirus expressing recombinant murine adiponectin (APN; 2 × 10 8 plaque forming unit (pfu)), and the remainder received a control adenoviral vector expressing β-galactosidase (β-gal; 2 × 10 8 pfu). Half of the mice in each group had pancreatitis induced by cerulein injection (50mcg/kg IP hourly for 6 h). The other half received saline on the same schedule. Serum APN concentration and pancreatic tissue concentrations of interleukin (IL)-6, IL-1β, and MCP-1 were measured by ELISA. Histologic pancreatitis score was calculated based on the degree of inflammation (0-4), edema (0-4), and vacuolization (0-4). Data were analyzed by ANOVA and Tukey's tests; p<0.05 was considered significant. Results: No difference in body weight was observed between groups. Serum APN was significantly upregulated in the APN group compared with the β-gal group. Pancreatic tissue concentration of IL-6 was significantly decreased in the APN group compared with the β-gal group. No change either in pancreatic tissue concentration of IL-1β and MCP-1 or in the severity of histologic pancreatitis were observed. Conclusion: Adiponectin upregulation modulates the pancreatic cytokine milieu but does not attenuate pancreatitis in this model of mild acute pancreatitis.

Original languageEnglish
Pages (from-to)1394-1400
Number of pages7
JournalJournal of Gastrointestinal Surgery
Volume15
Issue number8
DOIs
StatePublished - Aug 2011

Fingerprint

Adiponectin
Pancreatitis
Up-Regulation
Obesity
Obese Mice
Interleukin-1
Interleukin-6
Galactosidases
Ceruletide
Injections
Adipokines
Serum
Adenoviridae
Tail
Veins
Edema
Analysis of Variance
Appointments and Schedules
Anti-Inflammatory Agents
Enzyme-Linked Immunosorbent Assay

Keywords

  • Adenovirus
  • Adipokine
  • Adiponectin
  • Obesity
  • Pancreatitis

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Does Adiponectin Upregulation Attenuate the Severity of Acute Pancreatitis in Obesity? / Al-Azzawi, Hayder H.; Ziegler, Kathryn M.; Swartz-Basile, Deborah A.; Wang, Sue; Pitt, Henry A.; Zyromski, Nicholas.

In: Journal of Gastrointestinal Surgery, Vol. 15, No. 8, 08.2011, p. 1394-1400.

Research output: Contribution to journalArticle

Al-Azzawi, Hayder H. ; Ziegler, Kathryn M. ; Swartz-Basile, Deborah A. ; Wang, Sue ; Pitt, Henry A. ; Zyromski, Nicholas. / Does Adiponectin Upregulation Attenuate the Severity of Acute Pancreatitis in Obesity?. In: Journal of Gastrointestinal Surgery. 2011 ; Vol. 15, No. 8. pp. 1394-1400.
@article{2568ff3a3d4a43c9a732aff0cff25b62,
title = "Does Adiponectin Upregulation Attenuate the Severity of Acute Pancreatitis in Obesity?",
abstract = "Introduction: Obesity is an independent risk factor for severe acute pancreatitis, though the mechanisms underlying this association are unknown. The powerful anti-inflammatory adipokine adiponectin is decreased in obesity. We recently showed that the severity of pancreatitis in obese mice is inversely related to circulating adiponectin levels, and therefore hypothesized that adiponectin upregulation would attenuate the severity of pancreatitis in obese mice. Methods: Forty congenitally obese mice were studied. Seven days prior to study, 20 mice received a single tail vein injection of adenovirus expressing recombinant murine adiponectin (APN; 2 × 10 8 plaque forming unit (pfu)), and the remainder received a control adenoviral vector expressing β-galactosidase (β-gal; 2 × 10 8 pfu). Half of the mice in each group had pancreatitis induced by cerulein injection (50mcg/kg IP hourly for 6 h). The other half received saline on the same schedule. Serum APN concentration and pancreatic tissue concentrations of interleukin (IL)-6, IL-1β, and MCP-1 were measured by ELISA. Histologic pancreatitis score was calculated based on the degree of inflammation (0-4), edema (0-4), and vacuolization (0-4). Data were analyzed by ANOVA and Tukey's tests; p<0.05 was considered significant. Results: No difference in body weight was observed between groups. Serum APN was significantly upregulated in the APN group compared with the β-gal group. Pancreatic tissue concentration of IL-6 was significantly decreased in the APN group compared with the β-gal group. No change either in pancreatic tissue concentration of IL-1β and MCP-1 or in the severity of histologic pancreatitis were observed. Conclusion: Adiponectin upregulation modulates the pancreatic cytokine milieu but does not attenuate pancreatitis in this model of mild acute pancreatitis.",
keywords = "Adenovirus, Adipokine, Adiponectin, Obesity, Pancreatitis",
author = "Al-Azzawi, {Hayder H.} and Ziegler, {Kathryn M.} and Swartz-Basile, {Deborah A.} and Sue Wang and Pitt, {Henry A.} and Nicholas Zyromski",
year = "2011",
month = "8",
doi = "10.1007/s11605-011-1583-x",
language = "English",
volume = "15",
pages = "1394--1400",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Does Adiponectin Upregulation Attenuate the Severity of Acute Pancreatitis in Obesity?

AU - Al-Azzawi, Hayder H.

AU - Ziegler, Kathryn M.

AU - Swartz-Basile, Deborah A.

AU - Wang, Sue

AU - Pitt, Henry A.

AU - Zyromski, Nicholas

PY - 2011/8

Y1 - 2011/8

N2 - Introduction: Obesity is an independent risk factor for severe acute pancreatitis, though the mechanisms underlying this association are unknown. The powerful anti-inflammatory adipokine adiponectin is decreased in obesity. We recently showed that the severity of pancreatitis in obese mice is inversely related to circulating adiponectin levels, and therefore hypothesized that adiponectin upregulation would attenuate the severity of pancreatitis in obese mice. Methods: Forty congenitally obese mice were studied. Seven days prior to study, 20 mice received a single tail vein injection of adenovirus expressing recombinant murine adiponectin (APN; 2 × 10 8 plaque forming unit (pfu)), and the remainder received a control adenoviral vector expressing β-galactosidase (β-gal; 2 × 10 8 pfu). Half of the mice in each group had pancreatitis induced by cerulein injection (50mcg/kg IP hourly for 6 h). The other half received saline on the same schedule. Serum APN concentration and pancreatic tissue concentrations of interleukin (IL)-6, IL-1β, and MCP-1 were measured by ELISA. Histologic pancreatitis score was calculated based on the degree of inflammation (0-4), edema (0-4), and vacuolization (0-4). Data were analyzed by ANOVA and Tukey's tests; p<0.05 was considered significant. Results: No difference in body weight was observed between groups. Serum APN was significantly upregulated in the APN group compared with the β-gal group. Pancreatic tissue concentration of IL-6 was significantly decreased in the APN group compared with the β-gal group. No change either in pancreatic tissue concentration of IL-1β and MCP-1 or in the severity of histologic pancreatitis were observed. Conclusion: Adiponectin upregulation modulates the pancreatic cytokine milieu but does not attenuate pancreatitis in this model of mild acute pancreatitis.

AB - Introduction: Obesity is an independent risk factor for severe acute pancreatitis, though the mechanisms underlying this association are unknown. The powerful anti-inflammatory adipokine adiponectin is decreased in obesity. We recently showed that the severity of pancreatitis in obese mice is inversely related to circulating adiponectin levels, and therefore hypothesized that adiponectin upregulation would attenuate the severity of pancreatitis in obese mice. Methods: Forty congenitally obese mice were studied. Seven days prior to study, 20 mice received a single tail vein injection of adenovirus expressing recombinant murine adiponectin (APN; 2 × 10 8 plaque forming unit (pfu)), and the remainder received a control adenoviral vector expressing β-galactosidase (β-gal; 2 × 10 8 pfu). Half of the mice in each group had pancreatitis induced by cerulein injection (50mcg/kg IP hourly for 6 h). The other half received saline on the same schedule. Serum APN concentration and pancreatic tissue concentrations of interleukin (IL)-6, IL-1β, and MCP-1 were measured by ELISA. Histologic pancreatitis score was calculated based on the degree of inflammation (0-4), edema (0-4), and vacuolization (0-4). Data were analyzed by ANOVA and Tukey's tests; p<0.05 was considered significant. Results: No difference in body weight was observed between groups. Serum APN was significantly upregulated in the APN group compared with the β-gal group. Pancreatic tissue concentration of IL-6 was significantly decreased in the APN group compared with the β-gal group. No change either in pancreatic tissue concentration of IL-1β and MCP-1 or in the severity of histologic pancreatitis were observed. Conclusion: Adiponectin upregulation modulates the pancreatic cytokine milieu but does not attenuate pancreatitis in this model of mild acute pancreatitis.

KW - Adenovirus

KW - Adipokine

KW - Adiponectin

KW - Obesity

KW - Pancreatitis

UR - http://www.scopus.com/inward/record.url?scp=79960845606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960845606&partnerID=8YFLogxK

U2 - 10.1007/s11605-011-1583-x

DO - 10.1007/s11605-011-1583-x

M3 - Article

VL - 15

SP - 1394

EP - 1400

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 8

ER -